THE WELCH COMPANY
440 Davis Court #1602
San Francisco, CA 94111-2496
415 781 5700
rodwelch@pacbell.net


S U M M A R Y


DIARY: December 1, 2006 02:30 PM Friday; Rod Welch

Millie at Kaiser 15th cycle Xeloda Taxotere IBC relapse.

1...Summary/Objective
2...Treatment Regular 3 Week Schedule Steady Level Chemotherapy Agent
3...Breathing Difficulty Heavy Chest Pulmonary Emboli Side Effects
4...Side Effects Consultation Pharmacist Heavy Chest Difficult Breathing
5...Schedule Next Treatment Continue Fridays
6...Blood Counts Good Dose Chemotherapy Taxol Normal
....Anticoagulattion Therapy INR High 3.3 PT Patient High 33.0
7...ANC 2888 Well Above 1500 Criteria for Blood Counts Approve Treatment
8...CA 15-3 67 Rise from 61 Cancer Marker Current Blood Test
9...Preparation for Treatment Required One (1) Attempt to Connect Port
10...Benedryl Reduce Side Effects Taxotere Chemotherapy Treatment
11...Taxotere Full Dose Blood Counts on Targets
12...Vitals Show Patient Stable
13...Pharmacist Orders Capecitabine Decadron; Coordinate with Coumadin
14...Pulmonary Emboli Pharmacist Not Aware Communication Medication Fails
15...Procrit Prescription Kaiser Confirms Understandings on Guidance
16...Energy Normal Stable After Treatment Taxotere Support Drugs


..............
Click here to comment!

CONTACTS 

SUBJECTS
15th Cycle Treatment Taxotere Xeloda Capacitibine Chemotherapy 7th C

0503 -
0503 -    ..
0504 - Summary/Objective
0505 -
050501 - Follow up ref SDS A5 0000. ref SDS A2 0000.
050502 -
050503 - Treatment with Taxotere starts another 3-week cycle with capecitabine.
050504 - Blood counts are still pretty good, ref SDS 0 P560, and INR for
050505 - pulmonary embolism is okay on the high side, requiring moderating
050506 - Coumadin treatments. ref SDS 0 SE6N  CA 15-3 cancer marker keeps
050507 - rising further indicating the treatment protocol is becoming less
050508 - effective. ref SDS 0 2N5J  Hemoglobin is good, so treatment with
050509 - Procrit was not continued. ref SDS 0 LA5M  Masha submitted a letter on
050510 - instructions for taking Procrit 3 weeks ago.  Ing-Jeong Kim did a good
050511 - job presenting pharmacy issues, including review of side effects.
050512 - ref SDS 0 TZ4I  Abigail the nurse today was excellent setting up
050513 - treatment with Taxotere. ref SDS 0 P66O  After treatment, Millie felt
050514 - well enough to drive home. ref SDS A5 F54N
050515 -
050516 -    [On 070218 energy increases, shortness of breath, fatigue,
050517 -    weakness subside 10 weeks after ending treatment for 3rd
050518 -    relapse of IBC with Taxotere and cacecitabine; Millie is
050519 -    exercising in the gym again, playing tennis 2 days her pulse
050520 -    reached 144. ref SDS A8 N05H
050521 -
050522 -
050524 -  ..
0506 -
0507 -
0508 - Progress
0509 -
050901 - Treatment Regular 3 Week Schedule Steady Level Chemotherapy Agent
050902 -
050903 - Follow up ref SDS A5 407N, ref SDS A2 407N.
050904 -
050905 - Abigail brought Millie into the Infusion Clinic at 1445, about 15
050906 - minutes behind schedule.
050908 -  ..
050909 - Received treatment to begin 15th cycle overall of chemotherapy with
050910 - Taxotere and capecitabine (Xeloda), and the 7th treatment for 3rd
050911 - relapse of IBC.
050912 -
050913 -      1.  Cycle 09 and 01 for relapse........ 060721, ref SDS 85 407N
050914 -      2.  Cycle 10 and 02 for relapse........ 060814, ref SDS 93 LY6O
050915 -      3.  Cycle 11 and 03 for relapse........ 060908, ref SDS 96 407N
050916 -      4.  Cycle 12 and 04 for relapse........ 060929, ref SDS 98 407N
050917 -      5.  Cycle 13 and 05 for relapse........ 061020, ref SDS A2 407N
050918 -      6.  Cycle 14 and 06 for relapse........ 061110, ref SDS A5 407N
050919 -      7.  Cycle 15 and 07 for relapse........ 061201, ref SDS 0 407N
050920 -
050924 -  ..
050925 - Millie had a blood draw yesterday afternoon, Thursday, 061130.
050927 -  ..
050928 - As reported in another record, the primary care physician came into
050929 - the Infusion Clinic and asked Abigail to create a transaction in
050930 - Kaiser's computer system that schedules Millie to meet with the doctor
050931 - today. ref SDS A7 QS5N  The doctor said he would notify the nurse in
050932 - half an hour or so to bring Millie into the Oncology Clinic for the
050933 - meeting while she is getting treatment with Taxotere, as was done
050934 - previously on 060929. ref SDS 98 SB8G
050935 -
050936 -
050937 -
050938 -
050939 -
050940 -
050941 -
0510 -

SUBJECTS
Side Effects Consultation Pharmacist Tired Fatigue Heavy Chest Short

1603 -
160401 -  ..
160402 - Breathing Difficulty Heavy Chest Pulmonary Emboli Side Effects
160403 - Side Effects Consultation Pharmacist Heavy Chest Difficult Breathing
160404 -
160405 - Follow up ref SDS A5 QU8K, ref SDS A2 QU8K.
160406 -
160407 - On 060724 diary showing history of side effects for 2nd phase taking
160408 - Taxotere and capecitabine (Xeloda). ref SDS 87 QX8K
160410 -  ..
160411 - Millie met with the pharmacist, Ing-Juong Kim, briefly while getting
160412 - Taxotere treatment in the Infusion Clinic, examination per below, and
160413 - notified of rising side effects. ref SDS 0 TZ4I
160415 -             ..
160416 -            Tired, fatigued - pulmonary emoblism...
160417 -
160418 -               Millie's energy continues lower than normal for
160419 -               chemotherapy treatments; as reported previously on
160420 -               061110, chronic fatigue prevents routine exercise at the
160421 -               gym, ref SDS A5 SK9O, after starting Coumadin on 061002
160422 -               for treating pulmonary embolism. ref SDS A2 SK9O
160423 -               Fatigue continues after 3 weeks of treatment with
160424 -               Procrit prescribed on 061110 to increase hemoglobin that
160425 -               causes anemia. ref SDS A5 DT7O  Blood counts today show
160426 -               hemoglobin is now within target range, but symptoms of
160427 -               pulmonary embolism, and side effects of chemotherapy
160428 -               continue, as reported a few days ago on 061108.
160429 -               ref SDS A4 VR6F
160431 -                ..
160432 -               On 061110 these symptoms of pulmonary embolism were
160433 -               reported to primary care physician, ref SDS A6 VD4G, and
160434 -               again today, following treatment in the Infusion Clinic.
160436 -             ..
160437 -            Heavy chest - shortness of breathing
160438 -
160439 -               This condition remains a problem, as reported on 061110.
160440 -               ref SDS A5 UL6L  Normal exgertion walking up stairs,
160441 -               walking a few blocks from the BART station to the office
160442 -               in San Francisco, walking around at the shopping mall,
160443 -               cause shortness of breath, occassional chest discomfort,
160444 -               and and noticable fatigue.
160445 -
160447 -             ..
160448 -            Cough - clearing throat
160449 -
160450 -               This condition continues, and shows improvement,
160451 -               compared to the report on 061110. ref SDS A5 8N4G
160452 -               Concern that continual clearing of throat was reported
160453 -               in Millie's diary on 061108, ref SDS A4 VR6F, when this
160454 -               problem was presented in a letter to Millie. ref SDS A4
160455 -               TP61
160456 -
160458 -             ..
160459 -            Dry hands and feet...
160460 -
160461 -               Hands, fingers, cuticals bleeding slightly continues.
160462 -               Nails are separating from fingers and toes.  Feet and
160463 -               fingers now tingling, inflammation, swelling, called
160464 -               "hand-foot" syndrome, about the same.
160466 -             ..
160467 -            Eyes tearing
160468 -
160469 -               This has been a continuing problem, but increased the
160470 -               past treatment cycle.
160471 -
160473 -             ..
160474 -            Nausea
160475 -
160476 -               Problem previously resolved, as reported on 061110.
160477 -               ref SDS A5 D19M
160478 -
160480 -             ..
160481 -            Sores in mouth
160482 -
160483 -               None yet, cleaning mouth carefully to avoid problem.
160484 -
160485 -
160486 -
160487 -
160488 -
160489 -
160490 -
1605 -

SUBJECTS
Schedule Treatment Regular 3-week Cycle on Friday 061222 1430 Blood

2003 -
200401 -  ..
200402 - Schedule Next Treatment Continue Fridays
200403 -
200404 - Follow up ref SDS A5 QK6L, ref SDS A2 QK6L.
200406 -  ..
200407 - Today, Millie's next treatment is scheduled for 061222 1430.
200409 -  ..
200410 - Blood draw is schedued for the day before on 061221 1600.
200412 -  ..
200413 - Meeting with the doctor also scheduled for 061222.  Not sure about
200414 - the time, because we can do it before or during treatment.
200416 -  ..
200417 - This schedule presents a conflict with Millie's plans to have the
200418 - family over for Christmas eve.  This is usually about 20 people.
200419 - Takes a lot of energy for planning and prepraation.  This year,
200420 - Christmas eve will occur on Sunday, which will be the 2nd day after
200421 - treatment on Friday, 061222.  Millie will not be feeling well on
200422 - Sunday.
200424 -  ..
200425 - Possibly treatment could be moved to Monday or Tuesday, since Monday
200426 - is Christmas day.
200427 -
200428 -
200429 -
200430 -
200431 -
200432 -
200433 -
200434 -
2005 -

SUBJECTS
Blood Tests Chemotherapy WBC White Cell Count Good 15th Cycle Taxote

2503 -
250401 -  ..
250402 - Blood Counts Good Dose Chemotherapy Taxol Normal
250403 -
250404 - Follow up ref SDS A5 Q659, ref SDS A2 Q659.
250406 -  ..
250407 - Abigail submitted the report on the blood test yesterday on 061130
250408 - showing...
250409 -
250410 -    Patient   Provider  Category   View      FR Date   To Date
250416 -     ..
250417 -    Procedure              Results             Reference Range
250418 -
250422 -
250423 -                  ** Marina Way South **
250425 -     ..
250426 -    Test Name            Value Unit     <-------- RANGE-------->
250427 -    @CBC
250428 -    WBC x 10-3               3.8 K/uL           3.5   -     12.5
250429 -    RBC x 10-6              3.75 M/uL           3.60  -      5.70
250430 -    Hemoglobin              12.8 g/dL          11.5   -     15.0
250431 -    Hematocrit              37.7 %             34.0   -     46.0
250432 -    MCV             H        101 fL            80.0   -    100.0
250433 -    RDW             H       18.8 %             11.9   -     14.3
250434 -    Plt x10-3              337   K/uL         140     -    400
250435 -     ..
250436 -    Neutrophils     H        76  %             50     -     70
250437 -    Lymphocytes              23  %             20     -     50
250438 -    Monocyte                  1  %              0     -     11
250439 -    Eosinophils               0  %              1     -      5
250440 -    Basophil                  0  %              0     -      2
250441 -    Bands             No Report  %              0     -      5
250443 -     ..
250444 -    CA 15-3         H         67 U/mL          -<     -     39
250446 -     ..
250447 -    Alkaline Phos     No Report  U/L           38     -    126
250448 -    Bili, Tot Adult          0.4 mg/dL        0.2     -    1.3
250449 -    Creatinine              0.78 mg/dL        0.6     -    1.2
250450 -    ALT (SGPT)                41 U/L           11     -     66
250451 -    AST (SGOT)        No Report  U/L
250453 -     ..
250454 -    RBC Morphology    No Report
250455 -    Poikilocytosis  * No Report
250456 -    Anisocytosis    * No Report
250457 -    Schistocytes    * No Report
250458 -    PLT Estimate      No Report
250459 -    PLT Morphology    No Report
250460 -
250461 -
250462 -
250463 -
2505 -

SUBJECTS
Anticoagulation Therapy Pulmonary Emboli INR High 3.3 PT Patient Hig

2803 -
280401 -     ..
280402 -    Anticoagulattion Therapy INR High 3.3 PT Patient High 33.0
280403 -
280404 -    Follow up ref SDS A5 SE6N, ref SDS A2 SE6N.
280405 -
280406 -    PT, patient    H        33.0 sec           8.9    -     11.1
280407 -    PT INR         H         3.3 sec           2      -      3
280409 -  ..
280410 - Gloria called earlier this afternoon, and said to skip Coumadin on
280411 - Sunday in order to reduce INR to below 3.
280412 -
280413 -
280414 -
280415 -
2805 -

SUBJECTS
Absolute Neutrophils Count ANC 2888 Well Above 1500 Required for Tre

3103 -
310401 -  ..
310402 - ANC 2888 Well Above 1500 Criteria for Blood Counts Approve Treatment
310403 -
310404 - Follow up ref SDS A5 P560, ref SDS A2 P560.
310405 -
310406 - Millie has been worried lately that blood counts would not be high
310407 - enough for treatment, based on side effects reported to Kaiser this
310408 - afternoon, per above. ref SDS 0 SK9O  Experience since 2002 has shown
310409 - a strong correlation between feeling tired, reported today,
310410 - ref SDS A5 FG3N, and having low blood counts.
310412 -  ..
310413 - ANC seems to be dropping consistently, shown by reports...
310414 -
310415 -        6972................................ 060814, ref SDS 93 P560
310416 -        6390................................ 060908, ref SDS 96 P560
310417 -        5200................................ 060929, ref SDS 98 P560
310418 -        3869................................ 061020, ref SDS A2 P560
310419 -        2880................................ 061110, ref SDS A5 P560
310420 -        2888................................ 061201, ref SDS 0 P560
310422 -  ..
310423 - Formula for ANC, from record on 050128. ref SDS 50 TZ3N
310425 -  ..
310426 - Calculation from 060908 yielded 6390. ref SDS 96 P560
310428 -  ..
310429 - Note that bands are added to neutrophils, but both neutrophils and
310430 - bands have no report today.
310431 -
310432 -                  WBC               =   3.8
310433 -
310434 -                  Neutrophils       =    .76
310435 -                  Bands             =    no report
310437 -             ..
310438 -            ANC = 3.6 x 1000 x .76  = 2888  ???
310440 -  ..
310441 - ANC calculation was submitted by the nurse today.
310442 -
310443 -
310444 -
310445 -
310446 -
310447 -
3105 -

SUBJECTS
CA 15-3 67 Rise from 61 Cancer Marker Current Blood Test Reversing P

3303 -
330401 -  ..
330402 - CA 15-3 67 Rise from 61 Cancer Marker Current Blood Test
330403 -
330404 - Follow up ref SDS A5 2N5J, ref SDS A2 2N5J.
330406 -  ..
330407 - Report today for blood test yesterday showing CA 15-3 67, ref SDS 0
330408 - 5K6K, continues on slight increase compared to the report on 061110.
330409 - ref SDS A5 2N5J
330411 -  ..
330412 - There were actually two other CA 15-3 tests this period.  Recent
330413 - history shows...
330414 -
330415 -            061130......................... 67
330416 -            061116......................... 66
330417 -            061110......................... 56
330418 -            061109......................... 61
330420 -  ..
330421 - Reflects very slow progress of stable to worsening IBC rash on left
330422 - breast, as reported in the examination on 061110, ref SDS A6 RU6J, and
330423 - seen again today during follow up examination by the doctor.
330424 - ref SDS A7 025H
330425 -
330426 -
330427 -
330428 -
330429 -
330430 -
3305 -

SUBJECTS
Port Connection Prepare for Treatment 1 Try Required Abigail Excelle

3503 -
3504 - 1456
350501 -  ..
350502 - Preparation for Treatment Required One (1) Attempt to Connect Port
350503 -
350504 - Follow up ref SDS A5 EB7J, ref SDS A2 EB7J.
350506 -  ..
350507 - Another nurse did the administration with Abigail to verify Millie
350508 - gets the correct treatment.
350510 -  ..
350511 - Millie explained having taken Decadron tablets according to the
350512 - prescription to take two tablets twice a day, per instructions on
350513 - 050415. ref SDS 57 8U4O
350515 -  ..
350516 - Decadron was not given by Abigail again before treatment today,
350517 - because Millie took the pills this morning with her meal, as
350518 - prescribed; and Millie will take another treatment of Decadron
350519 - tomorrow as part of chemotherapy treatment with Taxotere today.
350520 -
350521 -        Generic name:  dexamethasone
350522 -
350523 -              http://www.tirgan.com/decadron.htm
350525 -         ..
350526 -        Description and purpose of Decadron is reported in the record
350527 -        on 060721. ref SDS 85 4I4Q
350529 -  ..
350530 - Compazine - Abigail gave Millie a pill prior to treatment.  Millie
350531 - took this with a cup of water; this was after Julie and Abigail did
350532 - the protocol verfication, per above, ref SDS A2 6O5G, which corrected
350533 - the mistake that occurred on 060929. ref SDS 98 NG55
350535 -  ..
350536 - Ativan - was not part of treatment today, previously given on 060721.
350537 - ref SDS 85 FZ5M
350538 -
350539 -        Generic name:  benzodiazepines
350540 -
350541 -        Purpose of Atiman reported on 060721. ref SDS 85 NF6K
350543 -  ..
350544 - Anzemet - was not part of treatment today, previously given on 060908.
350545 - ref SDS 96 O64I  This was reported ineffective on 060929. ref SDS 98
350546 - NR5F
350547 -
350548 -        Generic name:  dolasetron mesylate
350549 -
350550 -               http://www.anzemet.com
350551 -
350552 -
350553 -
350554 -
350556 -  ..
3506 -
3507 -
3508 - 1459
3509 -
350901 - Abigail connected the IV tubes to the port....
350903 -       ..
350904 -      Interlink System Vented Paclitaxel set
350906 -  ..
350907 - This was done without incident, very professional and competent.
350908 -
350909 -
350910 -
3510 -

SUBJECTS
Benadryl Drip Treatment Prepares Patient for Taxotere Chemotherapy A

3803 -
3804 - 1502
380501 -  ..
380502 - Benedryl Reduce Side Effects Taxotere Chemotherapy Treatment
380503 -
380504 - Follow up ref SDS A5 DC7J, ref SDS A2 DC7J.
380505 -
380506 - Benadryl started.
380508 -         ..
380509 -        Purpose reported on 060721. ref SDS 85 DC7J
380510 -
380511 -
380513 -  ..
3806 -
3807 -
3808 - 1512
3809 -
380901 - Benedryl completed equipment beeps.
380902 -
380903 - Barbara was treating the patient next to Millie, and so tended the
380904 - equipment.
380905 -
380906 -
380907 -
380908 -
3810 -

SUBJECTS
Taxotere 102 MG Drip Treatment 15th Cycle and 6th Cycle for IBC Rela

4003 -
4004 - 1513
400501 -  ..
400502 - Taxotere Full Dose Blood Counts on Targets
400503 -
400504 - Follow up ref SDS A5 4N5M, ref SDS A2 4N5M.
400506 -  ..
400507 - Taxotere started - 102 MG.
400509 -  ..
400510 - Barbara started Taxotere treatment, because she near at hand when the
400511 - beep signaled the end of Benedryl treatment. ref SDS 0 7R6H
400513 -  ..
400514 - There was no patient evaulation process today, which fits the
400515 - procedure the first time Millie was treated with Taxotere on 020610,
400516 - ref SDS 7 MR5I; later, on 050415 Kaiser performed patient evaluation
400517 - of side effects for Taxotere treatment. ref SDS 57 4333
400518 -
400520 -  ..
4006 -
4007 -
4008 - 1557
4009 -
400901 - A nurse from Oncology came into the Infusion Clinic and advised that
400902 - the doctor was ready to meet with Millie.  The nurse assisted Millie
400903 - walking over to Oncology while still connected to the IV for Taxotere
400904 - chemotherapy treatment, as planned earlier this afternoon, reported
400905 - above. ref SDS 0 4O9M
400906 -
400907 -
400909 -  ..
4010 -
4011 -
4012 - 1613
4013 -
401301 - Equipment beeped indicating treatment is over.
401302 -
401303 - Since Millie was in the Oncology Clinic waiting to meet with the
401304 - doctor, walked over to the Infusion Clinic and reminded Abigail to
401305 - disconnect Millie's IV.
401307 -  ..
401308 - Abigail came into the doctor's examination room, but only turned off
401309 - the equipment, so it would stop beeping.
401310 -
401312 -  ..
4014 -
4015 -
4016 - 1703
4017 -
401701 - After Millie's meeting with the primary care physician in the Oncology
401702 - Department, Abigail assisted Millie walking back to the Infusion
401703 - Clinic.
401705 -  ..
401706 - Abigail disconnected the IV tubes.
401708 -  ..
401709 - She inserted Herceptin to flush the port.
401711 -  ..
401712 - She then removed the needle from the port, and swabbed the needle
401713 - wound, and placed a temporary bandage.
401714 -
401715 -
401716 -
401717 -
401718 -
4018 -

SUBJECTS
Vitals Blood Pressure Pulse Temperature Taxotere 102 MG Drip Treatme

4303 -
4304 - 1513
430501 -  ..
430502 - Vitals Show Patient Stable
430503 -
430504 - Follow up ref SDS A5 AW4L, ref SDS A2 AW4L.
430505 -
430506 - Abigail took vitals after starting Taxotere drip treatment...
430507 -
430508 -                    Blood
430509 -    Date   Time     Pressure   Pulse  Temprtr  Weight   So2
430511 -     ..
430512 -    061201 1534..... 123  76     76     97.5    150
430513 -    061110 1534..... 136  83     73     97.0    150      98
430514 -    061020 1534..... 140  79     67     99.8    151      97
430515 -    060929 1452..... 141  78     66     98.3    149
430516 -    060908 1335..... 139  79     73     98.1    149
430517 -    060814 1610..... 139  80     59     98.2    151
430518 -    060722 1440..... 142  74     67     98.1    149
430519 -    060711.......... 172  87     54     97.5    147
430520 -    060623.......... 141  87     71     98.0    147
430521 -    060428.......... 129  73     80     99.4    149
430522 -    060217.......... 153  81     61     98.6    150
430523 -    050916.......... 120  80     80     98.5
430524 -
430525 -
430526 -
430527 -
4306 -

SUBJECTS
Pharmacist Orders Capecitabine (Xeloda) 15th Cycle Decadron Review S

4903 -
4904 - 1543
490501 -  ..
490502 - Pharmacist Orders Capecitabine Decadron; Coordinate with Coumadin
490503 - Pulmonary Emboli Pharmacist Not Aware Communication Medication Fails
490504 -
490505 - Follow up ref SDS A5 TZ4I, ref SDS A2 TZ4I.
490506 -
490507 - An Oncology pharmacist, Ing-Juong Kim, visited Millie during treatment
490508 - in the Infusion Clinic.  She verified that Millie is taking 1.5 pills
490509 - of capecitabine (Xeloda) twice a day.  Ing-Juong has ordered a
490510 - prescription for Millie to purchase capecitabine treatments at the 2nd
490511 - floor Pharmacy after treatment and meeting with the doctor today.
490513 -  ..
490514 - Ing-Juong asked Millie about side effects?
490516 -  ..
490517 - Millie reported side effects listed in the record shown above,
490518 - ref SDS 0 QU8K, and citing the patient's diary on 060724. ref SDS 87
490519 - IF9I
490520 -
490521 -
490522 -
490523 -
490524 -
4906 -

SUBJECTS
Pharmacist Submits Letter Explain Procrit Prescribed Treat Anemia Lo

5903 -
590401 -  ..
590402 - Procrit Prescription Kaiser Confirms Understandings on Guidance
590403 -
590404 - Since hemoglobin blood count is within the target range, per the test
590405 - report above, ref SDS 0 0N7Q, Procrit prescription was not continued
590406 - today.
590407 -
590408 - Masha said that she did not submit a letter confirming verbal guidance
590409 - on 061110 concerning Procrit, and contrary to Masha's plan to support
590410 - the patient, ref SDS A5 XE4J, because her boss told her not to send a
590411 - verbatim transcript of what was said.
590413 -  ..
590414 - We reviewed standard practice authenticating accuracy of verbal
590415 - communications in meetings and calls does not require verbatim
590416 - transcripts; case study on 011011 indicates this reduces productivity.
590417 - ref SDS 4 PJ8J  In this case Masha spoke for about 20 minutes.
590418 - Writing that summarizes important guidance assists the patient in
590419 - accurately carrying out objectives for prescribing treatment within
590420 - the doctor/patient partnership model presented in Kaiser's Healthwise
590421 - Handbood, reviewed on 990625. ref SDS 2 4185  Writing further provides
590422 - a binary check that what was said was correct, clear, concise, and
590423 - complete, as explained in POIMS. ref OF 7 21G6
590425 -  ..
590426 - Masha said she can do this.
590427 -
590429 -  ..
5905 -
5906 -
5907 - 2213
5908 -
590801 - Millie received ref DRT 1 0001 with a copy to the primary care
590802 - physician, and another person at kaiser, from Masha saying...
590803 -
590804 -    1.  I'd like to write to you regarding what we have discussed [on
590805 -        November 10, 2006, ref SDS A5 6Z8J] about your treatment with
590806 -        Procrit for chemotherapy-induced anemia. ref DRT 1 0001
590808 -         ..
590809 -    2.  Since your hemoglobin test was 10.8 at baseline, that indicates
590810 -        that you have anemia that is most likely associated with
590811 -        chemotheapy treatment.  We'd like to initiate a red blood cell
590812 -        growth factor (Procrit) to help improve your energy levels and
590813 -        maintaining your red blood cell counts. ref DRT 1 X35N
590815 -  ..
590816 - This confirms understandings from the meeting on 061110, showing
590817 - Kaiser prescribed Procrit when hemoglogin was below target range once
590818 - during this treatment phase for the 3rd relapse of IBC, but not for 2
590819 - prior phases when hemoglobin was low for 10 times. ref SDS A5 DT7O
590821 -  ..
590822 - Masha's letter from Kaiser continues...
590823 -
590824 -    3.  You will receive 30,000 units given under the skin once weekly,
590825 -        and we will order the iron test (a blood test to determine if
590826 -        you are also iron-deficient that may be one factor to cause
590827 -        anemia).  We'll follow up with you every 3-4 weeks, and
590828 -        evaluate your blood levels to adjust the Procrit dose as
590829 -        needed.  In the case if your iron test shows that you are iron
590830 -        deficient, we'll discuss about the addition of iron supplement
590831 -        to Procrit with you.  In clinical studies, about 60-70% of
590832 -        patients undergoing chemotherapy respond to Procrit, that is,
590833 -        to help maintain/improve the energy level and the Hgb levels.
590835 -         ..
590836 -    4.  The most common side effects associated with Procrit is
590837 -        irritation around injection sites.  Blood clots and
590838 -        cardiovascular problem such as heart attacks have also been
590839 -        reported, which occur rarely.
590841 -  ..
590842 - How does Procrit risk of blood clots and cardiovascular problems
590843 - relate to patient diagnosis with pulmonary embolism, and enlarged
590844 - right ventricle reported in findings of CT scan test on 060930,
590845 - received on 061012? ref SDS A1 294Q
590847 -  ..
590848 - Masha's letter from Kaiser continues...
590849 -
590850 -    5.  Please feel free to call the clinic if you have further
590851 -        questions.  We will also call you at home once a month to
590852 -        follow up on your results.
590853 -
590854 -
590855 -
590856 -
590857 -
590858 -
5909 -

SUBJECTS
Energy Normal Stable Alert Drive Home After Treatment IBC 3rd Relaps

6303 -
6304 - 1705
630501 -  ..
630502 - Energy Normal Stable After Treatment Taxotere Support Drugs
630503 -
630504 - Follow up ref SDS A5 F54N, ref SDS A2 F54N.
630505 -
630506 - Millie was alert after treatment today, and not wobbly nor
630507 - disoriented.
630509 -  ..
630510 - On 060724 diary side effects for 2nd phase taking Taxotere and
630511 - capecitabine (Xeloda). ref SDS 87 QX8K
630512 -
630513 -
630514 -
630515 -
630516 -
630517 -
630518 -
6306 -